Pharmafile Logo
Pharmafocus logo
Advanced Search

Press release

Showing 15 posts of 535 posts found.

Teitur Trophics Raises EUR 28M in Series A Financing to Advance the Development and Treatment for Neurodegenerative Diseases

March 14, 2023
Business Services

Aarhus, Denmark March 14th, 2023: Teitur Trophics (“Teitur”), a biotech company dedicated to developing new treatments for patients suffering from …

News
Press release

Newron announces 2022 financial results and provides outlook for 2023

March 14, 2023
Business Services

Milan, Italy, March 14, 2023, 7 am CET – Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company …

News
Press release

Cell and Gene Therapy Catapult opens new Process Analytical Technologies laboratory

March 14, 2023
Business Services

London, 14 March 2023: The Cell and Gene Therapy Catapult (CGT Catapult) today announces the opening of a new laboratory …

News
Press release

Scottish patients with the most aggressive form of viral hepatitis become first in UK to be offered routine NHS access to Hepcludex® (bulevirtide)

March 14, 2023
Business Services

Monday 13 March 2023, London, UK – Gilead Sciences Ltd today announced that the Scottish Medicines Consortium (SMC) has become …

News
Press release

Cingulate and Indegene Announce Joint Commercialization Agreement for Lead ADHD Candidate CTx-1301

March 13, 2023
Business Services

KANSAS CITY, KANSAS and PRINCETON, NEW JERSEY – March 13, 2023 – Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing …

News
Press release

BRITISH LAND AND AUSTRALIANSUPER ANNOUNCE LIFE SCIENCES AMBITION AT CANADA WATER

March 13, 2023
Business Services

13 March 2023

News
Press release

Calliditas Announces Primary Endpoint Successfully Met in Phase 3 NefIgArd Trial Evaluating Nefecon® in IgA Nephropathy

March 13, 2023
Business Services

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced positive topline results from the global, randomized, double-blind, placebo-controlled …

News
Press release

FlyPharma Europe, Vienna: 2023 conference officially launched

March 9, 2023
Business Services

FlyPharma Europe, Vienna: 2023 conference officially launched   FlyPharma Conferences is pleased to announce its seventh event in Europe, which …

News
Press release

MSD presents Phase 3 data for its Investigational Activin Signaling Inhibitor, in Adults with Pulmonary Arterial Hypertension on Background Therapy

March 9, 2023
Business Services

LONDON, UK, March 6, 2023 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) today announced …

News
Press release

Redx Announces RXC004 Topline Data From a Phase 2 Monotherapy Module

March 8, 2023
Business Services

Alderley Park, UK, 8 March 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

POLB 001 patent portfolio strengthened through granting of US patent

March 8, 2023
Business Services

8 March 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’),  a leading infectious disease focused biopharmaceutical …

News
Press release

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

March 7, 2023
Business Services

Parma, Italy and Solna, Sweden, March 7th, 2023 – Chiesi Farmaceutici S.p.A (“Chiesi Group”) and Affibody AB (“Affibody”) today announced …

News
Press release

Late-Breaking Phase 3 A DUE Data Show Investigational Single-Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Haemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)

March 6, 2023
Business Services

BEERSE, Belgium, 6 March, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase …

News
Press release

86% of pharma and biotech companies plan to invest in ‘digitally agile’ supply chains in the next 12 months

March 6, 2023
Business Services

LONDON 6th March 2023  86% of pharma and biotech companies say they plan to become more digitally agile, according to …

News
Press release

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for Pegunigalsidase Alfa for Treatment of Fabry Disease

March 3, 2023
Business Services

Manchester, UK, 3rd March 2023 – Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver …

News
Press release

Latest content

GSK pledges £45m to Fleming Initiative to fight AMR

May 16, 2024

NeuroSense partners with PhaseV on upcoming phase 3 ALS trial

May 16, 2024

AstraZeneca adds new heart failure target through collaboration with BenevolentAI

May 15, 2024

FDA approves Roche’s HPV self-collection screening option

May 15, 2024

NHS accepts Pfizer’s tafamidis for ATTR-CM treatment

May 14, 2024